J. Goldman & Co’s Pfizer PFE Stock Holding History

J. Goldman & Co’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$7.54M	Buy	+268,600	New	+$7.15M	0.22%	132
2025 Q4	–	Sell	-500,000	Closed	-$12.7M	–	691
2025 Q3	$12.7M	Buy	+500,000	New	+$12.3M	0.32%	95
2024 Q3	–	Sell	-697,500	Closed	-$19.5M	–	580
2024 Q2	$19.5M	Buy	+697,500	New	+$19.2M	0.55%	56
2024 Q1	–	Sell	-87,500	Closed	-$2.52M	–	495
2023 Q4	$2.52M	Buy	+87,500	New	+$2.65M	0.1%	172
2023 Q1	–	Sell	-50,000	Closed	-$2.56M	–	451
2022 Q4	$2.56M	Buy	+50,000	New	+$2.4M	0.13%	158
2022 Q3	–	Sell	-60,000	Closed	-$3.15M	–	465
2022 Q2	$3.15M	Buy	+60,000	New	+$3.06M	0.15%	156
2022 Q1	–	Sell	-40,500	Closed	-$2.39M	–	423
2021 Q4	$2.39M	Buy	+40,500	New	+$2.01M	0.13%	181
2021 Q3	–	Sell	-270,000	Closed	-$10.6M	–	432
2021 Q2	$10.6M	Buy	+270,000	New	+$10.5M	0.41%	63
2013 Q3	–	Sell	-71,356	Closed	-$1.9M	–	306
2013 Q2	$1.9M	Buy	+71,356	New	+$1.97M	0.19%	143

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

J. Goldman & Co's PFE Position: Q1 2026 in Review

J. Goldman & Co opened a new position in Pfizer (PFE) in Q1 2026: 21,856 shares worth $614K. The stake represents 0.02% of the portfolio and ranks #482 among its holdings. This is a return to the name: J. Goldman & Co previously reported a position in PFE as recently as Q1 2025.

J. Goldman & Co first reported a position in PFE in Q2 2013 and has held it in 11 quarters since. The position peaked at $8.25M in Q4 2024. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

J. Goldman & Co held 21,856 shares of Pfizer worth $614K as of Q1 2026.
Pfizer was a new J. Goldman & Co position in Q1 2026.
Pfizer made up 0.02% of J. Goldman & Co's portfolio in Q1 2026, its #482 holding.
J. Goldman & Co first reported a position in Pfizer in Q2 2013 and has held it in 11 quarters since.
J. Goldman & Co's Pfizer position peaked at $8.25M in Q4 2024.
2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on J. Goldman & Co's 13F filing for Q1 2026, filed 15 May 2026.